NO975365L - Benzopyraner og farmasöytiske sammensetninger inneholdende dem - Google Patents

Benzopyraner og farmasöytiske sammensetninger inneholdende dem

Info

Publication number
NO975365L
NO975365L NO975365A NO975365A NO975365L NO 975365 L NO975365 L NO 975365L NO 975365 A NO975365 A NO 975365A NO 975365 A NO975365 A NO 975365A NO 975365 L NO975365 L NO 975365L
Authority
NO
Norway
Prior art keywords
benzopyrans
pharmaceutical compositions
compositions containing
pharmaceutical
compositions
Prior art date
Application number
NO975365A
Other languages
English (en)
Other versions
NO975365D0 (no
NO314846B1 (no
Inventor
Paul W Manley
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO975365(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO975365D0 publication Critical patent/NO975365D0/no
Publication of NO975365L publication Critical patent/NO975365L/no
Publication of NO314846B1 publication Critical patent/NO314846B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19975365A 1995-05-24 1997-11-21 Benzopyraner, fremgangsmåter for deres fremstilling, samt anvendelse som farmasöytiske midler og farmasöytiske sammensetninger inneholdendedem NO314846B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds
PCT/EP1996/002257 WO1996037490A1 (en) 1995-05-24 1996-05-24 Benzopyrans and pharmaceutical compositions containing them

Publications (3)

Publication Number Publication Date
NO975365D0 NO975365D0 (no) 1997-11-21
NO975365L true NO975365L (no) 1998-01-15
NO314846B1 NO314846B1 (no) 2003-06-02

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975365A NO314846B1 (no) 1995-05-24 1997-11-21 Benzopyraner, fremgangsmåter for deres fremstilling, samt anvendelse som farmasöytiske midler og farmasöytiske sammensetninger inneholdendedem

Country Status (30)

Country Link
US (1) US5905156A (no)
EP (1) EP0828733B1 (no)
JP (1) JPH11505820A (no)
KR (1) KR100437981B1 (no)
CN (1) CN1077888C (no)
AR (1) AR004489A1 (no)
AT (1) ATE205204T1 (no)
AU (1) AU703276B2 (no)
BR (1) BR9609048A (no)
CA (1) CA2217821C (no)
CO (1) CO4700520A1 (no)
CZ (1) CZ294474B6 (no)
DE (1) DE69615019T2 (no)
DK (1) DK0828733T3 (no)
ES (1) ES2163634T3 (no)
FI (1) FI973992L (no)
GB (1) GB9510477D0 (no)
HU (1) HU222772B1 (no)
IL (1) IL118382A (no)
MY (1) MY114924A (no)
NO (1) NO314846B1 (no)
NZ (1) NZ309765A (no)
PL (1) PL184144B1 (no)
PT (1) PT828733E (no)
RU (1) RU2160735C2 (no)
SK (1) SK283215B6 (no)
TR (1) TR199701417T1 (no)
TW (1) TW421646B (no)
WO (1) WO1996037490A1 (no)
ZA (1) ZA964209B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
DK1535918T3 (da) * 2002-08-29 2011-01-10 Nissan Chemical Ind Ltd Fremgangsmåde til fremstilling af aminobenzopyranforbindelse
US7098340B2 (en) * 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(n-메틸치환술폰아미도)메틸-2h-1-벤조피란 유도체
PE20181003A1 (es) 2015-09-28 2018-06-26 Genentech Inc Compuestos terapeuticos y sus metodos de uso
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
WO2018175707A1 (en) * 2017-03-24 2018-09-27 Genentech, Inc. 4-piperidin-n-(pyrimidin-4-yl)chroman-7-sulfonamide derivatives as sodium channel inhibitors
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
GB9102803D0 (en) * 1991-02-11 1991-03-27 Ici Plc Pyridine compounds
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (no) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
CO4700520A1 (es) 1998-12-29
NO975365D0 (no) 1997-11-21
US5905156A (en) 1999-05-18
IL118382A0 (en) 1996-09-12
PT828733E (pt) 2002-02-28
CA2217821C (en) 2008-05-06
GB9510477D0 (en) 1995-07-19
EP0828733A1 (en) 1998-03-18
DE69615019D1 (de) 2001-10-11
PL324042A1 (en) 1998-05-11
DE69615019T2 (de) 2002-06-06
SK157797A3 (en) 1998-05-06
RU2160735C2 (ru) 2000-12-20
IL118382A (en) 2000-01-31
JPH11505820A (ja) 1999-05-25
AU703276B2 (en) 1999-03-25
MX9709004A (es) 1998-03-31
HK1014137A1 (en) 1999-09-24
DK0828733T3 (da) 2001-12-17
HUP9801751A2 (hu) 1999-06-28
MY114924A (en) 2003-02-28
WO1996037490A1 (en) 1996-11-28
SK283215B6 (sk) 2003-03-04
NZ309765A (en) 2000-01-28
TR199701417T1 (xx) 1998-02-21
HU222772B1 (hu) 2003-10-28
BR9609048A (pt) 1999-02-23
CN1077888C (zh) 2002-01-16
AR004489A1 (es) 1998-12-16
AU6000896A (en) 1996-12-11
TW421646B (en) 2001-02-11
KR19990021925A (ko) 1999-03-25
CN1185153A (zh) 1998-06-17
FI973992A7 (fi) 1997-12-09
ATE205204T1 (de) 2001-09-15
FI973992A0 (fi) 1997-10-17
CZ294474B6 (cs) 2005-01-12
PL184144B1 (pl) 2002-09-30
FI973992L (fi) 1997-12-09
CA2217821A1 (en) 1996-11-28
NO314846B1 (no) 2003-06-02
EP0828733B1 (en) 2001-09-05
KR100437981B1 (ko) 2004-07-16
HUP9801751A3 (en) 1999-08-30
ES2163634T3 (es) 2002-02-01
CZ368897A3 (cs) 1998-02-18
ZA964209B (en) 1997-11-24

Similar Documents

Publication Publication Date Title
NO975985L (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
IS4706A (is) Lyfjasamsetningar
NO975984D0 (no) Aromatiske forbindelser og farmasöytiske blandinger inneholdende dem
IS1947B (is) Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra
NO976128D0 (no) Forbindelser og farmasöytiske blandinger som inneholder dem
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
NO962606L (no) Farmasöytisk sammensetning
DK0747050T3 (da) Farmaceutiske sammensætninger indeholdende irbesartan
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
NO306114B1 (no) Substituerte 4-fenyltiazolderivater og farmasöytiske blandinger som inneholder dem
NO941374L (no) 5-acylamino-1,2,4-tiadiazoler, fremstilling derav og farmasöytiske blandinger inneholdende dem
NO975365D0 (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
FI960487L (fi) Bentsopyraaneja ja niitä sisältäviä farmaseuttisia koostumuksia
LV11727A (lv) Farmaceitiska kompozicija
FI943705L (fi) Farmaseuttiset koostumukset
NO308004B1 (no) Nye aminofenylfosfonsyreforbindelser og farmasøytiske sammensetninger inneholdende dem
FI973280A0 (fi) Farmaseuttinen koostumus
FI940726A7 (fi) Farmaseuttiset koostumukset
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL122191A0 (en) Pharmaceutical compositions containing substituted benzopyrans
DK0776328T3 (da) 8-fluoranthracycliner, fremgangsmåder til fremstilling deraf og farmaceutiske præparater indeholdende dem
BR9605777A (pt) Composição farmacêutica
NO964309D0 (no) Farmasöytisk sammensetning